Source tiers follow the hierarchy I use across PepPal and PeptideDosingProtocols.com see my full methodology for how I grade evidence
However, it may also cause more gastrointestinal side effects compared to semaglutide, making individual tolerance an important factor when choosing between the two
Flexibility: Month-to-month treatment with no contracts and easy cancellation
The decrease in HbA 1c of 0.88%-points (9.64 mmol/mol) in this study compares to a mean 0.9%-point decrease reported in the IGNITE study, an observational study ( n = 211) evaluating oral semaglutide use in routine clinical practice in participants with T2D in the USA [25], and to a mean 1.3% reduction in the Swedish cohort ( n = 195) of the SURE study, an observational study of subcutaneously administered semaglutide use in routine clinical practice [26]
The hazard ratio for the primary outcome plus heart failure hospitalization was 0.97 (95% CI: 0.85-1.10).The hazard ratio for hospitalization for heart failure was 0.96 (95% CI
Side Effects Comparison Since both medications affect gut hormones and slow gastric emptying, they cause similar side effects